1) Dyson wins UPC’s first Spanish injunction: first BSH-based preliminary injunction, first BSH injunction based on anchor defendant

The UPC’s Hamburg LD has granted the UPC’s first-ever Spanish injunction, and the Hague LD affirmed, by panel decision, an order in a different case involving non-UPC countries.

2) Federal judge finds Lindis patents unenforceable in leukemia drug dispute, Amgen dodges $50 million payment

The District of Delaware has found two patents asserted in a dispute between Lindis and Amgen over the latter’s leukaemia drug Blincyto “unenforceable due to inequitable conduct”, rendering a prior $50 million jury verdict against Amgen irrelevant.

3) ETRI files HEVC SEP lawsuit against Hisense with UPC shortly after suing Transsion over same patent

Korea’s ETRI is now enforcing the same HEVC patent against two different Chinese defendants: smartphone maker Transsion as well as TV maker Hisense.